Literature DB >> 8548388

CP-123,369: a potent, orally active immunosuppressive agent.

K Koch1, D C Hanson, M F Newborg, K Cooper, H G Fouda, M L Biehl, R M Shepard, C B Donovan, M S Biggers, M Ramchandani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8548388     DOI： 10.1007/bf01778322

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

Review 1.  FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

Authors:  J Liu
Journal:  Immunol Today       Date:  1993-06

2.  Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.

Authors:  M K Porayko; S C Textor; R A Krom; J E Hay; G J Gores; H E Wahlstrom; L Sanchez-Urdazpal; T Richards; P Crotty; S Beaver
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

3.  The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation.

Authors:  B M Meiser; R E Morris
Journal:  Transplantation       Date:  1991-03       Impact factor: 4.939

4.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.

Authors:  W M Flanagan; B Corthésy; R J Bram; G R Crabtree
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

Review 5.  The mechanism of action of cyclosporin A and FK506.

Authors:  S L Schreiber; G R Crabtree
Journal:  Immunol Today       Date:  1992-04

Review 6.  Glycobiology: a growing field for drug design.

Authors:  K A Karlsson
Journal:  Trends Pharmacol Sci       Date:  1991-07       Impact factor: 14.819
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.